Annual Reports

Title Documents

2016 Form 10-K

2015 Form 10-K

2014 Form 10-K

2013 Form 10-K

2012 Form 10-K

2011 Form 10-K

2010 Form 10-K

2009 Form 10-K/A; Amendment No. 2

2009 Form 10-K/A; Amendment No. 1

2009 Form 10-K

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

 

Our Pipeline